Bristol-Myers Squibb Co. (BMY)
BCBA
Closed
Oct 7, 2026
Day's Range
31,940.0052 wk Range
20,180.00Overview - BMY - Bristol-Myers Squibb Co.
Key Statistics
Valuation
Enterprise Value
105,344.53T
P/E (Trailing)
‪4.90‬
PEG Ratio
‪0.03‬
Price / Sales (TTM)
‪1,405.38‬
Price / Book
‪2.02‬
EV / EBITDA
‪3,653.43‬
Profitability
Gross Margin
‪71.27%‬
Profit Margin
‪18.87%‬
Operating Margin
‪34.41%‬
Return on Assets
‪10.71%‬
Return on Equity
‪46.59%‬
Ownership
Shares Outstanding
2.04B
Float
2.03B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪34,096.00‬
200-Day Avg
‪30,144.20‬
Dividends
Payout Ratio
‪18.43%‬
Frequency
Quarterly
Market Cap - BMY - Bristol-Myers Squibb Co.
Peers - BMY - Bristol-Myers Squibb Co.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- BMYBCBABristol-Myers Squibb Co.69.12TMarket Cap+35.08%52-week change4.90P/E (Trailing)‪18.87%‬Profit Margin
- SANBCBABanco Santander, S.A. CEDEAR1,257.20TMarket Cap+29.46%52-week change57.14P/E (Trailing)‪33.46%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR353.29TMarket Cap+38.30%52-week change11.00P/E (Trailing)‪21.48%‬Profit Margin
- GSKBCBAGlaxoSmithKline plc CEDEAR159.66TMarket Cap+22.83%52-week change16.85P/E (Trailing)‪14.52%‬Profit Margin
- AZNBCBAAstraZeneca PLC CEDEAR103.32TMarket Cap+22.93%52-week change6.68P/E (Trailing)‪17.02%‬Profit Margin
- ABBVBCBAAbbVie Inc. - Depositary Receipt75.56TMarket Cap+22.40%52-week change8.00P/E (Trailing)‪9.80%‬Profit Margin
- GILDBCBAGilead Sciences Inc.75.38TMarket Cap+31.12%52-week change4.84P/E (Trailing)‪-10.63%‬Profit Margin
Profile Summary - BMY - Bristol-Myers Squibb Co.
About
Bristol-Myers Squibb Co. is a globally renowned biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines. With a strong focus on serious diseases, the company's primary purpose is to address unmet medical needs in oncology, cardiovascular, immunoscience, and fibrosis through…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
